| Literature DB >> 35627640 |
Alshimaa R Azab1,2, Walid Kamal Abdelbasset1,3, Saud M Alrawaili1, Abbas Elbakry A Elsayed4,5, Mohammed Ibrahim Hajelbashir4, FatmaAlzahraa H Kamel6,7, Maged A Basha7,8.
Abstract
BACKGROUND: Congenital diaphragmatic hernia (CDH) is a life-threatening condition with long-term complications including respiratory tract infections, respiratory muscle weakness, and abnormal lung functions. This study was designed to ascertain the effects of chest resistance and chest expansion exercises on respiratory muscle strength, lung function, and chest mobility in children with post-operative CDH.Entities:
Keywords: chest expansion exercise; chest resistance exercise; diaphragmatic hernia; lung functions; respiratory muscle strength; thoracic excursion
Mesh:
Year: 2022 PMID: 35627640 PMCID: PMC9142097 DOI: 10.3390/ijerph19106101
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1The CONSORT flow diagram of the study.
Demographic and clinical characteristics.
| Characteristics | Control Group | Study Group | |
|---|---|---|---|
| Age, years | 12.2 ± 1.4 | 12.4 ± 1.5 | 0.699 |
| Gender, m/f | 9/7 | 10/6 | 0.719 |
| Body mass index, Kg/m2 | 20.8 ± 3.5 | 21.2 ± 3.3 | 0.742 |
| Hospitalization period, months | 2.1 ± 0.5 | 1.9 ± 0.7 | 0.359 |
| Classification of CDH defect, | |||
| B-defect | 9 (56.25) | 11 (68.75) | 0.465 |
| C-defect | 7 (43.75) | 5 (31.25) | |
| Affected side, | |||
| Left side | 11 (68.75) | 12 (75) | 0.694 |
| Right side | 5 (31.25) | 4 (25) | |
| Medical TTT, | |||
| Inhaled corticosteroid | 3 (18.75) | 5 (31.25) | 0.414 |
| Inhaled corticosteroid+ long-acting β2-agonist | 13 (81.25) | 11 (68.75) |
Significant difference at p ˂ 0.05; CDH: congenital diaphragmatic hernia; TTT: treatment.
Pre- and post-treatment differences intragroup and intergroup.
| Measures | Control Group | Study Group | Mean Difference | Group × Time Interaction | |
|---|---|---|---|---|---|
| η2 | |||||
| FVC, pred. | |||||
| Pre- | 77.2 ± 10.7 | 77.7 ± 11.2 | −0.5 (−8.41 to 7.41) | 0.005 | 0.16 |
| Post- | 81.3 ± 10.5 | 89.6 ± 9.8 | −8.3 (−15.6 to −0.97) | ||
| 0.265 | 0.001 | ||||
| FEV1, pred. | |||||
| Pre- | 70.6 ± 7.4 | 70.8 ± 7.8 | −0.2 (5.7 to 5.3) | ˂0.001 | 0.14 |
| Post- | 74.1 ± 7.2 | 81.5 ± 5.4 | −7.4 (−11.99 to −2.8) | ||
| 0.172 | ˂0.001 | ||||
| PImax, cmH2O | |||||
| Pre- | 39.4 ± 7.8 | 39.8 ± 8.1 | −0.4 (−6.14 to 5.34) | ˂0.001 | 0.15 |
| Post- | 41.2 ± 7.6 | 51.7 ± 6.8 | −10.5 (−15.71 to −5.3) | ||
| 0.411 | ˂0.001 | ||||
| Thoracic excursions, cm | |||||
| Pre- | 6.5 ± 1.3 | 6.7 ± 1.5 | −0.2 (−1.21 to 8.1) | 0.036 | 0.17 |
| Post- | 6.7 ± 1.4 | 7.8 ± 1.2 | −1.1 (−2.04 to −0.16) | ||
| 0.581 | 0.022 | ||||
All data are displayed as mean ± SD; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; PImax: maximal inspiratory pressure; η2: Eta square.